within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A12B_Potassium.A12BA51_PotassiumChlorideCombina;

model PotassiumChlorideCombina
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.8,
    Cl = 2.4999999999999998e-06,
    adminDuration = 600,
    adminMass = 600 / 1000000,
    adminCount = 1,
    Vd = 0.0005,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0008333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>PotassiumChlorideCombinations</td></tr><tr><td>ATC code:</td><td>A12BA51</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>600</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>150</td><td>mL/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Potassium chloride in combination with other substances is used as an electrolyte replenisher to treat or prevent hypokalemia, a condition in which there are lower-than-normal levels of potassium in the blood. The drug is widely approved and currently used for this therapeutic purpose as a supplement, often in patients requiring potassium replacement due to diuretic therapy, vomiting, or other causes of potassium loss.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals, as published data specifically for potassium chloride combination formulations with ATC A12BA51 is lacking.</p><h4>References</h4><ol><li><p>Sattarzadeh, M, &amp; Zlotkin, SH (1999). Iron is well absorbed by healthy adults after ingestion of double-fortified (iron and dextran-coated iodine) table salt and urinary iodine excretion is unaffected. <i>The Journal of nutrition</i> 129(1) 117–121. DOI:<a href=\"https://doi.org/10.1093/jn/129.1.117\">10.1093/jn/129.1.117</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9915886/\">https://pubmed.ncbi.nlm.nih.gov/9915886</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A12BA51 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end PotassiumChlorideCombina;
